Shimei Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Shimei Chen has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Dandan Sun
Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China; Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai, 200080, China; Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai, 200080, China; National Clinical Research Center for Eye Diseases, Shanghai, 20080, China; Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, 20080, China
1 shared publication- Fang Wei
Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, National Clinical Research Center for Eye Diseases, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China
1 shared publication - Feng Zhu
Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA
1 shared publication Jami Willette-Brown
Laboratory of Cancer Immunometabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, 21702, USA
1 shared publication- Jian Zhang
Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China
1 shared publication Mark Lewandoski
Cancer and Developmental Biology Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, 21702, USA
1 shared publication
Latest Publications
- Open Access
- 1 December 2020
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 132, 110856
C-CBL is required for inhibition of angiogenesis through modulating JAK2/STAT3 activity in ROP development
- 1 December 2020
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 132, 110856
Open AccessC-CBL is required for inhibition of angiogenesis through modulating JAK2/STAT3 activity in ROP development